Welcome. Who is here? What is this?

Here's news and info about three primary blood cancers, Lymphoma, Myeloma and Leukemia with a decided patient's perspective.  I hope this helps whether you're newly diagnosed or veteran survivor.  

       Is this You?              This is me.            We're Not Alone!    

 Is this You cancer patient    Click This is me    We are not alone, cancer warriors
Check my:Link to my blog


Twitter Feed

Click my Social Media, good stuff

YouTube -- https://www.youtube.com/user/JackWhelanAdvocate Twitter -- https://twitter.com/JackWhelan Google+ -- http://www.google.com/+JackWhelanAdvocate Facebook -- https://www.facebook.com/jack.whelan.98031

AACR Legislative: Write your Congressmen!


Professional Research Advocacy


American Association for Cancer Research


 American Society of Clinical Oncology 


Alliance for Clinical Research Excellence and Safety


National Organization for Rare Diseases 

Rare Disease Legislative Advocates  

Research Advocacy Network 

Alliance for Clinical Trials Oncology, Jack Whelan member

Patient Advocates In

Society for Participatory Medicine

Health Advocate Code of Conduct and Professional Standards

WEGO Health Speakers Bureau 

Connect With Me At ExpertFile


Music and audio player

As seen or quoted on these TV stations

ABC Good Morning America CBS Sunday Morning 2 News 3 News 8 10 News 12 News WIDK 10 28 News KCOY KCAU 9 KILL TV3 KLTV 7 KMPH 26 KOTA 28 News America my FOX LIVE HD 5 blip 28 News FOX-25 FOX-5 NEWS-25HD KYTX-19 NBC4i NBC29 ABC 33-40 WAND 17HD WBAY 2 WBOC 16 WECT 6 WHBQ 13 WITN WLBT 3 WMCT 5 WRCB 3 WSET 13 WTOC 11 WTVM 9 WVUE 8

Oral Chemo Parity Bill, railroaded off track at the 11th hour

At 11:30 PM last night I got a phone call from an 'insider' at the Commonwealth of Massachusetts State House saying don't expect any positive vote on the Oral Chemotherapy Parity bill before midnight.  This is an important countdown because at midnight on July 31, the regular legislative session comes to and end.   While emailing hopeful messages to the Leukemia & Lymphoma Society and volunteer team members that worked so hard championing approval of this bill, I didn't have the heart to report what I had heard... "it's over for now".  As someone at a senior level position at the State House rammed through an eleventh hour amendment that would neutralize this proposed legislation, it was clear our bill would never come up for a vote as the proposed amendment caused much confusion.  

Had I been on the side of the opponents, I'd say this was an exceptional, brilliant move to defeat this bi-partisan supported bill.  But, in this case everyone loses because Healthcare Providers will incur greater infusion care costs and capital expenditures needed to service the increasing patient population in infusion rooms where most facilities are operating a optimum capacity; Healthcare Insurance Companies will incur greater reimbursement costs as direct and indirect infusion are much more expensive that pill-form chemotherapy.  Most important are the thousands of cancer patients in the Commonwealth Of Massachusetts who have to pick up a greater share of their healthcare cost as these pill form agents are considered Pharmacy coverage where co-pays are high and chances that Insurance will cover these expense are low.   In addition, as most blood cancer patients have compromised immune systems, the most unhealthy place to go is a healthcare facility to sit with scores of other immuno-compromised cancer patients.  So round two comes to an end for now.  


From Ed Overton Jr. | On October 04, 2012 @10:12 pm
Chicago politics in Boston?

Leave a comment